Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
INVO Fertility ( (IVF) ) just unveiled an announcement.
On January 22, 2026, INVO Fertility, Inc. shareholders approved a major increase in authorized common stock from 6,250,000 to 250,000,000 shares and the company filed a corresponding amendment to its Articles of Incorporation the same day, significantly expanding its capacity to issue new equity. At a special meeting on January 22, 2026, stockholders also ratified the appointment of WithumSmith+Brown, PC as independent public accountant for 2025, approved the Nasdaq-related issuance of up to 4,733,728 shares upon exercise of a warrant from a December 4, 2025 private placement (plus any adjustment shares), authorized the expansion of the 2019 Stock Incentive Plan to 1,000,000 shares (about 10% of fully diluted outstanding stock), and endorsed potential adjournments for additional proxy solicitation, collectively enhancing INVO Fertility’s financial flexibility, capacity for capital raising, and ability to use equity-based incentives.
The most recent analyst rating on (IVF) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Neutral.
The score is held back primarily by weak financial quality—ongoing losses, sharp gross-margin compression, and negative operating/free cash flow. Technicals are moderately supportive in the near term (price above 20/50-day averages) but carry overbought risk and negative MACD. Corporate events are constructive (financing plus clinic expansion efforts) but do not yet outweigh the current profitability and cash-flow challenges.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
INVO Fertility, Inc. operates in the fertility and reproductive health industry, focusing on fertility treatments and related reproductive medical services for patients seeking assisted reproductive technologies.
Average Trading Volume: 5,982,863
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.89M
For a thorough assessment of IVF stock, go to TipRanks’ Stock Analysis page.